대한결핵및호흡기학회 KATRDKATRDIC 2024

GNB 메뉴 보기

KATRD 2024 International Conference
November 8(Thu)-10(Fri), 2024 Lotte Hotel World, Seoul, Kore
Program

Program

Program in Detail

Thursday, November 9

Oral Presentation 01
Pulmonary Infection and Bronchiectasis 1
Thursday, November 9
10:30-12:00
PEARL(3F)
Chair Youjin Chang (Inje University, Korea)
10:30-10:40 OP 01-1 Association of Air Pollutant Exposure with Mortality in COVID-19: A Multicenter Retrospective Study
Seohyun Kim (The Catholic University of Korea, Korea)
10:40-10:50 OP 01-2 Psychiatric Disorders Following COVID-19 Vaccination in South Korea: A National Retrospective Cohort Study
Yune-Young Shin (Ewha Womans University, Korea)
10:50-11:00 OP 01-3 Clinical Profile and Outcome of Vaccinated and Unvaccinated COVID-19 Patients Admitted at the University of Santo Tomas Hospital Between March 2021 to March 2022
Jaret Chessrence Consul (University of Santo Tomas, Philippines)
11:00-11:10 OP 01-4 Respiratory and Functional Outcomes Among Severe COVID-19 Infection Survivors: A Prospective Observational Study
Maria Kamal (Tunku Azizah Hospital, Malaysia)
11:10-11:20 OP 01-5 Epidemiology and Risk Factors of Fungal Pathogens in Sepsis
Song I Lee (Chungnam National University, Korea)
11:20-11:30 OP 01-6 Incidence and Temporal Feature of Community-acquired Pneumonia along with Seasons in Korea
Chansoo Youk (The Catholic University of Korea, Korea)
11:30-11:40 OP 01-7 Micro and Macroscopic Trends in Pneumonia and Respiratory Virus Infections: A Comparative Analysis of Mutual Influences and External Factors
Moonjin Kim (The Catholic University of Korea, Korea)
11:40-11:50 OP 01-8 Characteristics, Risk Factors and Management of Severe Bronchiolitis in Children Admitted to the Pediatric Unit of the Tizi-Ouzou University Hospital
Sofia Makhlouf (Mouloud Mammeri University, Algeria)
11:50-12:00 OP 01-9 The Effects of Engineered Extracellular Vehicles Rich in Let-7i-5p microRNA on Counteracting the Adverse Effects of Endotoxin in Mice
Van Long Le (Taipei Medical University, Taiwan)
Oral Presentation 04
TB/NTM (Mycobacterial Diseases) 1
Thursday, November 9
10:30-12:00
RUBY(3F)
Chair Yong-Soo Kwon (Chonnam National University , Korea)
10:30-10:40 OP 04-1 Incidence and Risk Factors of Tuberculosis in Patients Following Gastrectomy or Endoscopic Submucosal Dissection: A Cohort Analysis of Country-level Data
Sun Ha Choi (Kyungpook National University, Korea)
10:40-10:50 OP 04-2 Tuberculosis Survivors and the Risk of Cardiovascular Disease: Analysis Using a Nationwide Survey in Korea
Jiyoul Yang (Chungbuk National University, Korea)
10:50-11:00 OP 04-3 The Impact of SARS-CoV-2 Infection on Pulmonary Tuberculosis: A Nationwide Cohort Study
Dong Won Park (Hanyang University, Korea)
11:00-11:10 OP 04-4 Impact of Pyrazinamide Usage on Serious Adverse Events in Elderly Tuberculosis Patients
JoonYoung Yoon (Chonnam National University, Korea)
11:10-11:20 OP 04-5 Factors Associated with Depression Among Elderly Tuberculosis Patients: A Prospective Multi-center Cohort Study
Ahran Kim (The Catholic University of Korea, Korea)
11:20-11:30 OP 04-6 Unsuccessful Tuberculosis Treatment Outcomes and its Determinants Among TB/HIV Co-infected Patients in Malaysia: A Registry-based Study
Peter Seah Keng Tok (National Institutes of Health, Malaysia)
OP 04-7 CANCELED
HIV-TB Coinfection Among Clients Attending an Integrated Counselling & Testing Centre (ICTC)
Shiv Kumar Yadav (Govt LBS PG College, India)
11:30-11:40 OP 04-8 Do Patients Attempt and Succeed in Quitting Smoking During Tuberculosis Treatment? A Prospective Cohort Study
Jiwon Lee (The Catholic University of Korea, Korea)
Oral Presentation 07
Critical Care
Thursday, November 9
10:30-12:00
JADE (3F)
Chair Gee Young Suh (Sungkyunkwan University, Korea)
10:30-10:40 OP 07-1 Obesity Paradox in Long-term Mortality of Sepsis
Won Jin Lee (Pusan National University, Korea)
10:40-10:50 OP 07-2 Influence of Underlying Condition and Performance of Sepsis Bundle in very Older Patients with Sepsis
Song I Lee (Chungnam National University, Korea)
10:50-11:00 OP 07-3 Mapping the Correlations Between Serum Amino Acids and AKI Biomarkers in Sepsis ICU Patients
Hey Soo Kim (Yonsei University, Korea)
11:00-11:10 OP 07-4 Incidence and Outcome Analysis of Sepsis According to Adult Sepsis Event’s Simplified eSOFA Criteria: A Single-center Retrospective Study in South Korea
Suyeon Lee (University of Ulsan, Korea)
11:10-11:20 OP 07-5 Impact of Elevated Troponin Level on the Clinical Outcomes of Sepsis and Septic Shock Patients: A Nationwide Prospective Cohort Study
Eunjeong Choi (Sungkyunkwan University, Korea)
11:20-11:30 OP 07-6 Adjunctive Dobutamine has No Impact on Hospital Outcomes in Patients with Septic Shock: A Propensity-score Matching Analysis
Kyu Jin Lee (Hallym University, Korea)
11:30-11:40 OP 07-7 The Role of Pendrin in Acute Lung Injury/Acute Respiratory Distress Syndrome Caused by Ventilator Induced Lung Injury
Ji Soo Choi (Yonsei University, Korea)
11:40-11:50 OP 07-8 An Optimal Timing and Volume of Fluid Resuscitation in Patients with Sepsis: A Prospective Nationwide Multicenter Cohort Study
Dong-gon Hyun (University of Ulsan, Korea)
11:50-12:00 OP 07-9 Blockade of SIRT1 Ameliorates Endotoxin-induced Acute Lung Injury Through Modulation of Mitochondrial Reactive Oxygen Species
Yong Chul Lee (Jeonbuk National University, Korea)
Oral Presentation 02
Pulmonary Infection and Bronchiectasis 2
Thursday, November 9
13:30-14:40
PEARL(3F)
Chair Seung Won Ra (University of Ulsan, Korea)
13:30-13:40 OP 02-1 Reciprocal Enhancement of SARS-CoV-2 and Influenza Virus Replication in Human Pluripotent Stem Cell-derived Lung Organoids
Min Jung Kim (Korea National Institute of Health, Korea)
13:40-13:50 OP 02-2 Diverse Non-fatal Immune-related Adverse Events Following COVID-19 Vaccination in South Korea Using the National Health Insurance Service Database from 2020 to 2021
Jee Hyun Suh (Ewha Womans University, Korea)
13:50-14:00 OP 02-3 Impact of Immunosuppressant Usage and Vaccination Rates on COVID-19 Outcomes in Immunocompromised Patients: A Matched Cohort Study
Mindong Sung (Yonsei University, Korea)
14:00-14:10 OP 02-4 Comparison of Clinical Characteristics Between Cough Dominant and Sputum Dominant Group in Bronchiectasis: Findings from KMBARC Registry
Iseul Yu (Yonsei University, Korea)
14:10-14:20 OP 02-5 Spirometry-defined Ventilatory Defects and Risk of Acute Exacerbation in Patients with Bronchiectasis: The Prospective KMBARC Cohort Study
Jang Ho Lee (University of Ulsan, Korea)
14:20-14:30 OP 02-6 Association Between Sputum Myeloperoxidase Concentration and Bronchiectasis Status
Hyeokjun Yun (Z-Biotech, Korea)
14:30-14:40 OP 02-7 Effectiveness of Inhaled Ciprofloxacin in Treating Non-cystic Fibrosis Bronchiectasis- A Meta-analysis
Balwan Singh (KIET Group of Institutions, India)
Oral Presentation 05
TB/NTM (Mycobacterial Diseases) 2
Thursday, November 9
13:30-15:00
RUBY(3F)
Chair Ju Sang Kim (The Catholic University of Korea, Korea)
13:30-13:40 OP 05-1 The Role of Nested Polymerase Chain Reaction in Diagnosing Pulmonary and Extra-pulmonary Tuberculosis from Formalin-fixed Paraffin-embedded Tissue
Hyun Ah Lee (Ajou University, Korea)
13:40-13:50 OP 05-2 The Potential of Probiotic-based Therapy as a Tuberculosis Treatment via Gut-lung Axis: Enhancing Gut Microbiota, Mincle Receptor, Cytokines, Drug Efficacy, TB Prevention: A Narrative Review
Nadyatul Husna (Andalas University, Indonesia)
13:50-14:00 OP 05-3 Comparison of the Sputum Microbiome Between Stable Nontuberculous Mycobacteria Pulmonary Disease Patients and Those Requiring Antibiotic Treatment
Minjong Song (Sungkyunkwan University, Korea)
14:00-14:10 OP 05-4 Early Treatment versus Watchful Waiting in Mycobacterium avium Complex Pulmonary Disease: A Propensity Score Matched Analysis
Areum Hwang (Seoul National University, Korea)
14:10-14:20 OP 05-5 The Association Between Sputum Culture-conversion and Mortality in Cavitary Mycobacterium avium Complex Pulmonary Disease
Ju Kwang Lee (University of Ulsan, Korea)
14:20-14:30 OP 05-6 Factors Associated with Recurrence and Mortality in Mycobacterium avium Complex Pulmonary Disease
Jae-Kyeong Lee (Chonnam National University, Korea)
14:30-14:40 OP 05-7 Clinically Significant Hemoptysis is Associated with All-cause Mortality in NTM-PD Patients: Analysis of a Prospective Cohort Study
Kwonhyung Hyung (Seoul National University, Korea)
14:40-14:50 OP 05-8 Medical Costs Among Patients with Nontuberculous Mycobacterial Pulmonary Disease in South Korea
Shihwan Chang (Yonsei University, Korea)
14:50-15:00 OP 05-9 Bibliometric Analysis of Nontuberculous Mycobacteria Research in Korea
Geunin Lee (Yonsei University, Korea)
Oral Presentation 08
Pulmonary Vascular, Pleural and Sleep
Thursday, November 9
13:30-15:00
JADE (3F)
Chair Kwang Joo Park (Ajou University, Korea)
13:30-13:40 OP 08-1 Effect of Steroid Usage on Occurrence of Pulmonary Embolism in Patients with COPD: Korean Nationwide Study
Hun-Gyu Hwang (Soon Chun Hyang University, Korea)
13:40-13:50 OP 08-2 Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Automatic Diagnosis Using Two-stage Classification with Multiple Instance Learning
Ma Yang Zhao (The Hong Kong Polytechnic University, Hong Kong)
13:50-14:00 OP 08-3 Diagnosis of TB Pleurisy with Medical Thoracoscopy; A Novel Specimen, Targeted Pleural Washing Fluid After Pleural Biopsy
Yu Jin Hong (The Catholic University of Korea, Korea)
14:00-14:10 OP 08-4 Frozen Section During Medical Thoracoscopy for the Diagnosis of Tuberculous Pleurisy
Yun Seok Kim (The Catholic University of Korea, Korea)
14:10-14:20 OP 08-5 A Two-year Analysis of Indwelling Pleural Catheter Utilization for Recurrent Pleural Effusion: Insights from a Tertiary-center Perspective
Kughanishah Jeyabalan (Hospital Sultanah Bahiyah, Malaysia)
14:20-14:30 OP 08-6 Serum Matrix Metallopeptidase 9 as a Potential Biomarker for Hypoxemia Severity in Obstructive Sleep Apnea
So Yeon Kim (Seoul National University, Korea)
14:30-14:40 OP 08-7 Prevalence of the High-risk Group for Obstructive Sleep Apnea Based on the STOP-bang Questionnaire and its Association with Cardiovascular Morbidity
Jieun Kang (Inje University, Korea)
14:40-14:50 OP 08-8 Obstructive Sleep Apnea Increases the Risk of Venous Thromboembolism: A Nationwide Population-based Cohort Study in Korea
So Yeon Kim (Seoul National University, Korea)
Oral Presentation 03
Airway 1
Thursday, November 9
15:30-17:10
PEARL(3F)
Chair Ju Ock Na (Soon Chun Hyang University, Korea)
15:30-15:40 OP 03-1 New-onset Asthma after COVID-19 Infection: A Nationwide Population-based Cohort Study
Bo-Guen Kim (Hanyang University, Korea)
15:40-15:50 OP 03-2 Asthma History and Children Health Development in Indonesia
Riska Dwi Astuti (Universitas Islam Indonesia, Indonesia)
15:50-16:00 OP 03-3 Deep Learning Model for Smartphone-recorded Cough Sounds: A Prospective Study in Predicting Asthma
Kyoung Min Moon (Chung-Ang University, Korea)
16:00-16:10 OP 03-4 Developing the Prediction Model for Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Youlim Kim (Konkuk University, Korea)
16:10-16:20 OP 03-5 Development of a Scoring System to Predict Suboptimal Peak Inspiratory Flow in Patients with Chronic Obstructive Pulmonary Disease
Sang Hyuk Kim (Dongguk University, Korea)
16:20-16:30 OP 03-6 Network Analysis Comparing Subgroups of Heterogenous COPD Patients
Hyeon-Kyoung Koo (Inje University, Korea)
16:30-16:40 OP 03-7 Understanding Impulse Oscillometry
Hyeon-Kyoung Koo (Inje University, Korea)
16:40-16:50 OP 03-8 The Potential of Impulse Oscillometry as a Diagnostic Tool for Assessing Respiratory Function in Various COPD Subtypes
A Reum Han (Konkuk University, Korea)
16:50-17:00 OP 03-9 Imputing Missing Data Improves the Accuracy of Machine Learning Models for Predicting Exacerbation of Chronic Obstructive Pulmonary Disease
Sang Hyuk Kim (Dongguk University, Korea)
17:00-17:10 OP 03-10 Utilizing Deep Learning for Smartphone-recorded Cough Sounds: A Prospective Study in Screening Respiratory Diseases
Kyoung Min Moon (Chung-Ang University, Korea)
Oral Presentation 06
Miscellaneous
Thursday, November 9
15:30-17:00
RUBY(3F)
Chair Hun-Gyu Hwang (Soon Chun Hyang University, Korea)
15:30-15:40 OP 06-1 Hematological Abnormalities After Vaccination for COVID-19; A Large Population-based Cohort Study
Hye Sook Choi (Kyunghee University, Korea)
15:40-15:50 OP 06-2 Impact of Preoperative Sarcopenia on Lung Transplantation Outcomes
Hyunjun Park (Seoul National University, Korea)
15:50-16:00 OP 06-3 Risk Factors Associated with COVID-19 Mortality Among Patients with or without Chronic Respiratory Diseases in Algeria: A Retrospective Cohort Study
Idir Ramdani (Biotechnology and Health Lab, Algeria)
16:00-16:10 OP 06-4 The Relationship Between Neutrophil-Lymphocytes Ratio and Duration of Hospitalization in Neonatal Respiratory Distress Syndrome Patient
Rafik Prabowo (Region General Hospital of Rokan Hulu, Indonesia)
OP 06-5 CANCELED
The Burden of Chronic Respiratory Disease and Attributable Risk Factors in Pakistan- A Systematic Analysis of Global Burden of Disease Study (GBD) 2019
Taymmia Ejaz (The Aga Khan University, Pakistan)
16:10-16:20 OP 06-6 Warfarin Management in Patients Taking Rifampin: A Single-center Experience
Jinwoo Seok (Soon Chun Hyang University, Korea)
16:20-16:30 OP 06-7 The Lung Transplantation Economic Analysis in Asia
Pisi Bethania Titalessy (Cenderawasih University, Indonesia)
16:30-16:40 OP 06-8 Impact of Smoking Behavior Changes on Pneumonia Hospitalization in Smokers with Diabetes Mellitus
Dong-Woo Han (University of Ulsan, Korea)
16:40-16:50 OP 06-9 Socioeconomic Factors and Tobacco Smoking Among Adult Males in Indonesia: A Cross-sectional Regression
Salman Samir (Universitas Hasanuddin, Indonesia)
Oral Presentation 09
Lung Cancer 1
Thursday, November 9
15:30-17:00
JADE (3F)
Chair Yoon Soo Chang (Yonsei University, Korea)
15:30-15:40 OP 09-1 Characterization of T Cell Subsets Within Malignant Pleural Effusion in Lung Cancer Patients in Comparison to Benign Pleural Effusion and Paired PBMC
Duk Ki Kim (Chungnam National University, Korea)
15:40-15:50 OP 09-2 Understanding BRG1-deficient NSCLC: Clinical Implications and Therapeutic Strategies
Yunjoo Im (Sungkyunkwan University, Korea)
15:50-16:00 OP 09-3 Prognostic Significance of Soluble Programmed Death Ligand 1 (sPD-L1) in Bronchoalveolar Lavage Fluid (BALF) in Non-small Cell Lung Cancer (NSCLC) Patients
So Yun Kim (Chungnam National University, Korea)
16:00-16:10 OP 09-4 Immune Checkpoint Inhibitor Score (IChIS) Predicts Survival Benefit of Immunotherapy in Non-small Cell Lung Cancer Patients
Da Hyun Kang (Chungnam National University, Korea)
16:10-16:20 OP 09-5 Impact of Concomitant Genetic Alterations on EGFR-TKI Efficacy by Targeted NGS Analysis: A Multicenter Prospective and Real World Study
In Ae Kim (Konkuk University, Korea)
16:20-16:30 OP 09-6 Treatment Outcomes and Factors Associated with Repeated Rebiopsy for the Detection of EGFR T790M Mutation in Advanced Stage NSCLC
Taeyun Kim (Sungkyunkwan University, Korea)
16:30-16:40 OP 09-7 Impact of PD-L1 Expression on the Development of EGFR TKI Resistance
Junsu Choe (Sungkyunkwan University, Korea)
16:40-16:50 OP 09-8 Assessment of TMB Based on Whole Exome Sequencing Using Extracellular Vesicles-derived DNA Obtained from Bronchoalveolar Lavage Fluid (BALF) in Advanced NSCLC Patients Treated
Heejoung Kim (Konkuk University, Korea)
OP 09-9 CANCELED
Discovery of Gallic Acid-Metformin Based Novel AMPK/mTOR Kinase Inhibitor Against Non-small Cell Lung Cancer (NSCLC)
Vikas Kumar (AAI-DU, India)

Friday, November 10

Oral Presentation 10
Airway 2
Friday, November 10
10:20-11:50
PEARL(3F)
Chair Woo Jin Kim (Kangwon National University, Korea)
10:20-10:30 OP 10-1 Symptom Burden of Patients with Chronic Obstructive Pulmonary Disease Attending a Breathlessness Service: Prevalence, Associations and Sex-related Differences
Jin-Gun Cho (Westmead Hospital, Australia)
10:30-10:40 OP 10-2 Decline in Muscle Mass Index Predicts Lung Function Decline in the General Population.
Joon Young Choi (The Catholic University of Korea, Korea)
10:40-10:50 OP 10-3 Impaired Diffusing Capacity is Associated with Acute Exacerbation Independent of Emphysema in Chronic Obstructive Pulmonary Disease
Hyun Woo Lee (Seoul National University, Korea)
10:50-11:00 OP 10-4 Clinical Characteristics of Chronic Obstructive Pulmonary Disease Patients with Super-optimal Peak Inspiratory Flow Rate: A Multi-center Cross-sectional Study in South Korea
Taeyun Kim (Sungkyunkwan University, Korea)
11:00-11:10 OP 10-5 Clinical Significance of Normalized Airflow Obstruction in Patients with Chronic Obstructive Pulmonary Disease in Korean Loco-regional Population-based Cohort; From Korean Genome and Epidemiology Study
Yun Seok Kim (The Catholic University of Korea, Korea)
11:10-11:20 OP 10-6 Comparison of Health Practice Score to Reduce Exposure of Particulate Matter in Various Groups of Susceptible and Vulnerable Individuals
Hyejin Park (Yonsei University, Korea)
11:20-11:30 OP 10-7 Causative Pathogen and Clinical Features in Acute Exacerbations of Chronic Obstructive Pulmonary Disease After COVID-19
Soo Jung Kim (Hallym University, Korea)
11:30-11:40 OP 10-8 Clinical Characteristic of Patients with COPD-A
Jong Min Lee (The Catholic University of Korea, Korea)
11:40-11:50 OP 10-9 The Value of COPD Assessment Test in Perioperative Assessment of Patients with Mild to Moderate COPD
Bora Lee (University of Ulsan, Korea)
Oral Presentation 13
ILD 1
Friday, November 10
10:20-11:50
RUBY(3F)
Chair Soo-Taek Uh (Soon Chun Hyang University, Korea)
10:20-10:30 OP 13-1 Safety, Effectiveness, and Usefulness of Higher-dose Tablets of Generic Pirfenidone in Patients with IPF: A Nationwide Observational Study in South Korea
Jieun Kang (Inje University, Korea)
10:30-10:40 OP 13-2 Pirfenidone Reduces the Risk of Lung Cancer Development in IPF: A Nationwide Population Based Study
Hee-Young Yoon (Soon Chun Hyang University, Korea)
10:40-10:50 OP 13-3 Development of a Prediction Model for Acute Exacerbation in Idiopathic Pulmonary Fibrosis: A Study of the Korea IPF Cohort Registry
Jae Ha Lee (Inje University, Korea)
10:50-11:00 OP 13-4 Mortality in IPF Patients Based on FVC and DLCO: A Simple Staging System Adapted for Korean
Kyung Hoon Kim (The Catholic University of Korea, Korea)
11:00-11:10 OP 13-5 Prognostic and Categorize Index for Idiopathic Pulmonary Fibrosis
Jib Yong Jung (Soon Chun Hyang University, Korea)
11:10-11:20 OP 13-6 The King’s Brief Interstitial Lung Disease Questionnaire in IPF: A Validation Study in Korean Patients with IPF
Seong Min Kim (Armed Forces Capital Hospital, Korea)
11:20-11:30 OP 13-7 The Korea IPF Cohort (KICO) Registry: Association Between air Pollution and Health Outcomes
Hee-Young Yoon (Soon Chun Hyang University, Korea)
11:30-11:40 OP 13-8 Impact of Air Trapping Quantified by Residual Volume and Total Lung Capacity for Idiopathic Pulmonary Fibrosis
Tae Hun Kim (Keimyung University, Korea)
11:40-11:50 OP 13-9 The Impact of Antacids on Overall Survival in Patients with Idiopathic Pulmonary Fibrosis
Jin-Young Huh (Chung-Ang University, Korea)
Oral Presentation 16
Lung Cancer 2
Friday, November 10
10:20-11:50
JADE (3F)
Chair Hak Ryul Kim (Wonkwang University, Korea)
10:20-10:30 OP 16-1 Factors Associated with Postoperative Recurrence in Stage I to IIIA Non-small Cell Lung Cancer with Epidermal Growth Factor Receptor Mutation: Analysis of Korean National Population Data
KyuYean Kim (The Catholic University of Korea, Korea)
10:30-10:40 OP 16-2 Genetic Alterations and Risk Factors for Recurrence in Patients with Non-small Cell Lung Cancer who Underwent Complete Surgical Resection
Hwa Kyung Park (Chonnam National University, Korea)
10:40-10:50 OP 16-3 Durvalumab Consolidation after Concurrent Chemoradiotherapy in Elderly Patients with Unresectable Stage III NSCLC
June Hong Ahn (Yeungnam University, Korea)
10:50-11:00 OP 16-4 Real-world Data of Durvalumab Consolidation after CCRT in Unresectable Stage III EGFR Mutant NSCLC: A Multicenter Study
June Hong Ahn (Yeungnam University, Korea)
11:00-11:10 OP 16-5 Neoadjuvant Laertinib Therapy for Potentially Resectble EGFR-Mutated NSCLC Detected by EV-based BALF Liquid Biopsy : Interim Analysis
In Ae Kim (Konkuk University, Korea)
11:10-11:20 OP 16-6 Gefitinib Maintenance After Definitive CCRT in EGFR Mutant Stage III NSCLC: Single Arm, Open Label, Multicenter Phase 2 Pilot Trial
Yoon-Sil Jang (University of Ulsan, Korea)
11:20-11:30 OP 16-7 Clinical Course of Multi-synchronous Subsolid Nodules in Patients with Resected Lung Adenocarcinoma
Seyoung Jung (Seoul National University, Korea)
11:30-11:40 OP 16-8 A Phase 2, Multicenter, Single Arm Study to Evaluate the Efficacy of Lazertinib in Patients with NSCLC Who Harboring EGFR T790M Mutation Detected by BALF Liquid Biopsy: Interim Analysis
Heejoung Kim (Konkuk University, Korea)
11:40-11:50 OP 16-9 The Treatment Outcomes of Patients with Subsolid-type Lung Cancer who Underwent SBRT or SBPT
So Rae Kim (Sungkyunkwan University, Korea)
Oral Presentation 11
Airway 3
Friday, November 10
14:40-16:10
PEARL(3F)
Chair Deog Kyeom Kim (Seoul National University, Korea)
14:40-14:50 OP 11-1 Association of Preserved Ratio Impaired Spirometry (PRISm) with All-Cause Mortality: A Longitudinal Cohort Study
Yunjoo Im (Sungkyunkwan University, Korea)
14:50-15:00 OP 11-2 Incidence of Tuberculosis Associated COPD: Multicenter Retrospective Cohort Study
Dong-Hyun Joo (Seoul National University, Korea)
15:00-15:10 OP 11-3 Exploring the Impact of Combined Pulmonary Fibrosis and Emphysema and Other Radiological Manifestations in Chronic Obstructive Pulmonary Disease
Tai Joon An (The Catholic University of Korea, Korea)
15:10-15:20 OP 11-4 Exacerbation and Lung Function Change According to Small Airway Disease and Progression in Patients with COPD
Donghyeong Koo (Seoul National University, Korea)
15:20-15:30 OP 11-5 Use of Eosinophil Guided Systemic Corticosteroid Therapy in Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-analysis
Sanjeev Kharel (Tribhuvan University, Nepal)
15:30-15:40 OP 11-6 Impact of Smoking Reduction on Lung Cancer Risk in Patients with COPD who Smoked 30 Pack-years or Less: A Nationwide Population-based Cohort Study
Taeyun Kim (Sungkyunkwan University, Korea)
15:40-15:50 OP 11-7 The Effect of Tiotropium/Olodaterol Combination Treatment on Cardiopulmonary Exercise Test in COPD Patients (ACHIEVE): A Single-center, Single-arm Prospective Interventional Study
Hye Soo Kim (Yonsei University, Korea)
15:50-16:00 OP 11-8 Adherence to the Guideline Recommendations in COPD Management of South Korea
Sang Min Han (Jeonbuk National University, Korea)
16:00-16:10 OP 11-9 Dual Bronchodilator Therapy over Triple Therapy as an Initial Treatment in Chronic Obstructive Pulmonary Disease Patients with One Moderate Exacerbation
Sun Hye Shin (Sungkyunkwan University, Korea)
Oral Presentation 14
ILD 2
Friday, November 10
14:40-16:10
RUBY(3F)
Chair Sei Hoon Yang (Wonkwang University, Korea)
14:40-14:50 OP 14-1 Establishment of a Repetitive Intratracheal Bleomycin Model Resembling Feature of Usual Interstitial Pneumonia in Aged Mice
Yun Ha Nam (Soon Chun Hyang University, Korea)
14:50-15:00 OP 14-2 Long Term Inhalation of PM 2.5 Deteriorates Pre-existing Lung Fibrosis via Enhancing Epithelial to Mesenchymal Transition and Mitochondrial Dysfunction in Mice.
Sung Woo Park (Soon Chun Hyang University, Korea)
15:00-15:10 OP 14-3 Transcriptomic Effects of Targeting Mitochondrial Oxidative Stress on Environmental Compound-induced Lung Injury and Fibrosis in Mice
Jae Seok Jeong (Jeonbuk National University, Korea)
15:10-15:20 OP 14-4 The Association Between Changes in KL-6 Levels and Lung Function in Idiopathic Pulmonary Fibrosis (IPF)
Hyeon Kyeong Bae (Yonsei University, Korea)
15:20-15:30 OP 14-5 Role of Blood Krebs von Lungen-6 for Predicting Acute Exacerbation In Patients with IPF
Ji Hoon Jang (Inje University, Korea)
15:30-15:40 OP 14-6 Role of Lipid Metabolites in Exhaled Breath as Biomarkers in Idiopathic Pulmonary Fibrosis
Ju Hyun Oh (Inje University, Korea)
15:40-15:50 OP 14-7 Automatic Classification and Decision Supporting System for Usual Interstitial Pneumonia in Chest Computed Tomography Using Convolutional Neural Network
Kyoung Min Moon (Chung-Ang University, Korea)
15:50-16:00 OP 14-8 Imaging Signatures in Idiopathic Pulmonary Fibrosis (IS-IPF): Two CT Image-based Biomarkers for Predicting Progression in Fibrosing Interstitial Lung Diseases
Ju Hyun Oh (Inje University, Korea)
16:00-16:10 OP 14-9 Development of a Digital Biomarker from Pulmonary Function Tests of Patients with Interstitial Lung Disease (ILD) to Predict Their Long-term Survival
Juye Bae (Seoul National University, Korea)
Oral Presentation 17
Lung Cancer 3
Friday, November 10
14:40-16:10
JADE (3F)
Chair Ji Woong Son (Konyang University, Korea)
14:40-14:50 OP 17-1 Lazertinib as 2nd or More Line is More Effective in Patients who Showed Long Duration of Response to Prior TKI in Advanced NSCLC
Jeong Uk Lim (The Catholic University of Korea, Korea)
14:50-15:00 OP 17-2 The Impact of Immune Checkpoint Inhibitor Approval on Treatment Patterns in Elderly Patients with Stage IV NSCLC
Inhan Lee (Seoul National University, Korea)
15:00-15:10 OP 17-3 Nicotinamide in Combination with EGFR-TKIs for the Treatment of Stage IV Lung Adenocarcinoma with EGFR Mutations: A Randomized Double Blind (Phase IIb) Trial
Hyung-Joo Oh (Chonnam National University, Korea)
15:10-15:20 OP 17-4 Comparative Analysis of Brigatinib and Alectinib as Second-Generation ALK Tyrosine Kinase Inhibitors in the Treatment of Advanced NSCLC with ALK Rearrangements
Kyuhwan Kim (The Catholic University of Korea, Korea)
15:20-15:30 OP 17-5 Response to Prior Platinum-based Chemotherapy is Correlated with Immunotherapy Response in NSCLC with Low or Negative PD-L1 Expression
Kyuhwan Kim (The Catholic University of Korea, Korea)
15:30-15:40 OP 17-6 Efficacy and Safety of First-generation EGFR TKI Retreatment in Patients who Were Not Induced T790M After Sequential Treatment of First- or Second-generation EGFR TKI and Cytotoxic Chemotherapy.
Juwhan Choi (Korea University, Korea)
15:40-15:50 OP 17-7 Treatment Patterns in Elderly Patients with Metastatic Non-small Cell Lung Cancer in the Era of Immunotherapy
Hye Seon Kang (The Catholic University of Korea, Korea)
15:50-16:00 OP 17-8 Real-world Treatment Outcomes and Safety of Afatinib in Advanced Squamous Cell Lung Cancer Progressed after Platinum-based Doublet Chemotherapy and Immunotherapy (Space Study)
Seung Hyeun Lee (Kyung Hee University, Korea)
Oral Presentation 12
Bronchoscopy and Intervention Pulmonology
Friday, November 10
16:20-17:50
PEARL(3F)
Chair Sang Haak Lee (The Catholic University of Korea, Korea)
16:20-16:30 OP 12-1 A Predictive Strategy for the Successful Sampling of Lung Lesion Using Radial Endobronchial Ultrasound Based on the Prediction Model.
Hyunseung Nam (Sungkyunkwan University, Korea)
16:30-16:40 OP 12-2 Usefulness of the Multimodal Biopsy Approach in Radial EBUS Biopsy for Peripheral Lung Lesions
Donghyun Lee (University of Ulsan, Korea)
16:40-16:50 OP 12-3 Endobronchial Ultrasound Using Guide Sheath-guided Transbronchial Lung Biopsy in Ground-glass Opacity Pulmonary Lesions
Chang Woon Kim (Yeungnam University, Korea)
16:50-17:00 OP 12-4 Clinical Outcomes of Transbronchial Cryobiopsy Using 1.1 mm Diameter Cryoprobe for Peripheral Lung Lesions - A Prospective Pilot Study
Jung Seop Eom (Pusan National University, Korea)
17:00-17:10 OP 12-5 Diagnostic Accuracy of Cryo 1.1mm Probe Peripheral Lesion: With or Without Over Sheath
Geunin Lee (Yonsei University, Korea)
17:10-17:20 OP 12-6 An Optimal Approach for Diagnosing Peripheral Lung Nodules Using Combination of Electromanetic Navigation Bronchoscopy and Radial Probe Endobronchial Ultrasound
Bora Lee (University of Ulsan, Korea)
17:20-17:30 OP 12-7 Safety and Efficacy of Remimazolam Compared with Midazolam during Bronchoscopy: A Single Center, Randomized Controlled Study
Sun-Hyung Kim (Chungbuk National University, Korea)
17:30-17:40 OP 12-8 Laser Therapy in the Bronchoscoic Treatment of Airway Disease in One Hospital
KiHyun Seo (Soon Chun Hyang University, Korea)
17:40-17:50 OP 12-9 Role of Frozen Section During Medical Thoracoscopy for Decision Making in a Country with Decreasing TB Burden
Yu Jin Hong (The Catholic University of Korea, Korea)
Oral Presentation 15
ILD 3
Friday, November 10
16:20-17:50
RUBY(3F)
Chair Yong Hyun Kim (The Catholic University of Korea, Korea)
16:20-16:30 OP 15-1 Association Between the Use of Angiotensin Receptor Blockers/Calcium Channel Blockers and Risk of Interstitial Lung Disease/Idiopathic Pulmonary Fibrosis: A Nationwide Cohort Study
Hye Jin Jang (Myongji Hospital, Hanyang University, Korea)
16:30-16:40 OP 15-2 Increased Risk of Incident ILD Following COVID-19: A Nationwide Retrospective Cohort Study
Sun Young Paik (Hanyang University, Korea)
16:40-16:50 OP 15-3 Effect of COVID-19 Pandemic on Hospital Admissions for Idiopathic Pulmonary Fibrosis: A Nationwide Population-based Study
In-So Cho (Yonsei University, Korea)
16:50-17:00 OP 15-4 Progressive Pulmonary Fibrosis: Prevalence and Clinical Outcome in Korean Patients with Fibrosing ILD Other than IPF
Min Jee Kim (University of Ulsan, Korea)
17:00-17:10 OP 15-5 Rheumatoid Arthritis and Risk of Interstitial Lung Disease According to Serologic Status: A Nationwide Longitudinal Cohort Study
Bo-Guen Kim (Hanyang University, Korea)
17:10-17:20 OP 15-6 Interstitial Lung Disease Positive for Myositis Specific Antibodies
Seong Hwan Youn (Yonsei University, Korea)
17:20-17:30 OP 15-7 Progressive Pulmonary Fibrosis in Systemic Sclerosis-associated Interstitial Lung Disease: Prevalence and Clinical Outcomes
Kyung-Il Han (University of Ulsan, Korea)
17:30-17:40 OP 15-8 Malnutrition is Associated with Decreased Lung Function and Mortality in Sjögren’s Syndrome-associated Interstitial Lung Disease
Eunki Chung (Yonsei University, Korea)
17:40-17:50 OP 15-9 Exploration of Cough Patterns with AI-based Cough Monitor in Patients with Interstitial Lung Disease and Asthma Exacerbations
Jong Sun Park (Seoul National University, Korea)
Oral Presentation 18
Lung Cancer 4
Friday, November 10
16:20-17:50
JADE (3F)
Chair Chi Young Jung (Daegu Catholic University, Korea)
16:20-16:30 OP 18-1 Protective Effect of Naringin Mediated Silver Nanoparticles in Human Lung Cancer Cell Lines Through Regulating SIRT1/AMPK Signaling Pathway by Inducing Pro-Apoptotic Autophagy
Ekta Yadav (Sam Higginbottom University, India)
16:30-16:40 OP 18-2 Evaluating the Impact and Challenges of AI-assisted CXR Analysis in the Detection of Lung Nodules and Incidental Lung Cancers
Eun Hye Lee (Yonsei University, Korea)
16:40-16:50 OP 18-3 Screening, Overdiagnosis, and Medicalization of Lung Cancer: A Nationwide Population-based Ecological Cohort Study in Korea
So Yeon Kim (Seoul National University, Korea)
16:50-17:00 OP 18-4 Incidence of Lung Cancer Among the Patients with Connective Tissue Disease
Sung Jun Chung (Korea University, Korea)
17:00-17:10 OP 18-5 Lung Cancer Risk Associated with Arsenic Levels in Drinking Water: A Meta-analysis
Rao Nargis Jahan (School of Pharmaceutical Education and Research, India)
17:10-17:20 OP 18-6 Managing EGFR Mutant Lung Adenocarcinoma with Tyrosine Kinase Inhibitors: A Pulmonology-Centered Approach at a Tertiary Facility in Northern Malaysia
Kughanishah Jeyabalan (Hospital Sultanah Bahiyah, Malaysia)
17:20-17:30 OP 18-7 Association of Air Pollution Exposure and Greenness on Risk of Lung Cancer in South Korea
Nam Eun Kim (Ewha Womans University, Korea)
17:30-17:40 OP 18-8 Therapeutic Potential of Lantadene and Peronemin Derivatives from Peronema Canescens: Molecular Docking and Computational Insights Targeting BRAF-EGFR Signaling in Non-Small Cell Lung Cancer (NSCLC)
Rizki Rachmad Saputra (Universitas Palangka Raya, Indonesia)

Go Top

© The Korean Academy of Tuberculosis and Respiratory Diseases


Contact Secretariat of KATRDIC 2024
ASSEMBLE  Room 816, Starlit Seongsu Bldg., 104 Achasan-ro, Seongdong-gu, Seoul, Korea